Boston Scientific (BSX) Other Non-Current Liabilities (2009 - 2026)
Boston Scientific (BSX) posted quarterly Other Non-Current Liabilities of $2.5 billion for Q2 2026, up 4.07% year-over-year from $2.4 billion in Q2 2025, and little changed on a QoQ basis from $2.5 billion in Q1 2026.
Boston Scientific (BSX) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Boston Scientific has reported Other Non-Current Liabilities for 18 years, with the latest figure at $2.5 billion in Q2 2026.
- Other Non-Current Liabilities for Q2 2026 came in at $2.5 billion, up 4.07% year-over-year; the trailing twelve-month figure through Jun 2026 was $2.5 billion (up 4.07% YoY), and the FY2025 annual result was $2.4 billion, up 28.61% from the prior year.
- Other Non-Current Liabilities held at $2.5 billion in Q2 2026, from $2.5 billion in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $2.5 billion in Q2 2026 and troughed at $1.8 billion in Q2 2024.
- A 5-year average of $2.1 billion and a median of $2.0 billion in 2022 frame the typical range for Other Non-Current Liabilities.
- The widest annual swing landed in 2022, when Other Non-Current Liabilities slipped 16.55%; it then soared 32.39% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $2.0 billion in 2022, then declined by 3.34% to $2.0 billion in 2023, then decreased by 4.93% to $1.9 billion in 2024, then climbed by 28.61% to $2.4 billion in 2025, then gained by 3.12% to $2.5 billion in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $2.5 billion in Q2 2026, $2.5 billion in Q1 2026, and $2.4 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.38 Bn | 196.77 Bn | 7.27 Bn |
| 2 | Stryker | 126.28 Bn | 122.80 Bn | 4.50 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.10 Bn | 73.56 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.67 Bn | 47.42 Bn | 1.35 Bn |
| 6 | Dexcom | 35.07 Bn | 33.12 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.28 Bn | 18.87 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.48 Bn |
| Mar 31, 2026 | 2.47 Bn |
| Dec 31, 2025 | 2.41 Bn |
| Sep 30, 2025 | 2.39 Bn |
| Jun 30, 2025 | 2.38 Bn |
| Mar 31, 2025 | 1.95 Bn |
| Dec 31, 2024 | 1.87 Bn |
| Sep 30, 2024 | 1.84 Bn |
| Jun 30, 2024 | 1.80 Bn |
| Mar 31, 2024 | 1.92 Bn |
| Dec 31, 2023 | 1.97 Bn |
| Sep 30, 2023 | 1.86 Bn |
| Jun 30, 2023 | 1.93 Bn |
| Mar 31, 2023 | 2.00 Bn |
| Dec 31, 2022 | 2.04 Bn |
| Sep 30, 2022 | 1.92 Bn |
| Jun 30, 2022 | 1.99 Bn |
| Mar 31, 2022 | 2.00 Bn |
| Dec 31, 2021 | 2.22 Bn |
| Sep 30, 2021 | 2.30 Bn |